# The Metabolite Identification and Material Balance Study of SP2086

> **NCT02815748** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** SP2086

## Key facts

- **NCT ID:** NCT02815748
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815748, "The Metabolite Identification and Material Balance Study of SP2086". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02815748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*